This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
- Notice of Extraordinary Shareholders’ Meeting in Promore Pharma AB (publ)
- Promore Pharma Rights issue – correction of date
- Promore Pharma Promore Pharma carries out a rights issue of approximately SEK 75 million, underwritten up to 80 percent, and intends to publish its interim report early
- Promore Pharma AB (publ) Interim report January – June 2019